ArticleBMC pulmonary medicine2021

ID1 mediates resistance to osimertinib in EGFR T790M-positive non-small cell lung cancer through epithelial-mesenchymal transition.

Kejun Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.